Ignite Creation Date:
2025-12-25 @ 12:06 AM
Ignite Modification Date:
2026-02-24 @ 11:10 AM
Study NCT ID:
NCT02728258
Status:
COMPLETED
Last Update Posted:
2022-02-15
First Post:
2016-03-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Copanlisib in Treating Patients With Persistent or Recurrent Endometrial Cancer
Sponsor:
NRG Oncology
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-09-16
Start Date Type:
ACTUAL
Primary Completion Date:
2018-08-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2020-02-14
Completion Date Type:
ACTUAL
First Submit Date:
2016-03-30
First Submit QC Date:
None
Study First Post Date:
2016-04-05
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-23
Results First Submit QC Date:
None
Results First Post Date:
2020-03-06
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-25
Last Update Post Date:
2022-02-15
Last Update Post Date Type:
ACTUAL